The Journal of Immunoassay and Immunochemistry (April 2010, Volume 31) has published a peer-reviewed journal article written by Dr Andrea Small-Howard and Mr. Holden Harris titled “Advantages of the AMDL-ELISA DR-70 (FDP) Assay Over Carcinoembryonic Antigen (CEA) for Monitoring Colorectal Cancer Patients.”
Read MoreEpistem plc, the UK biotechnology and contract research company, will present details of their new plucked hair immunohistochemistry platform at the American Association for Cancer Research Annual Meeting in Washington DC on Tuesday April 20.
Read MoreHigh out-of-pocket costs, lack of health insurance and limited access to care contribute to a relatively low rate of colorectal cancer screening in the United States, according to a new systematic review by researchers.
Read MoreThe National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for a two-year study, which will focus on development of novel, recombinant-based diagnostic tests for the Ebola and Marburg viruses.
Read MoreCaliper Life Sciences Inc announced a non-exclusive OEM agreement with Access Genetics to market Caliper’s LabChip GX microfluidic system for molecular diagnostic applications.
Read More